Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cyteir Therapeutics, Inc. - Common Stock (NQ:CYT)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cyteir Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >
Cyteir Therapeutics to Participate in the 2022 Bank of America Healthcare Conference
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics Names Krisztina Nemenyi as Senior Vice President of Regulatory Affairs and Quality
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics Names Adam Veness General Counsel
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics to Host Virtual Research and Development (R&D) Day on April 26, 2022
From Cyteir Therapeutics
Via Business Wire
68 Biggest Movers From Yesterday
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core... 
Via Benzinga
Cyteir Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
From Cyteir Therapeutics
Via Business Wire
64 Biggest Movers From Yesterday
Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:... 
Via Benzinga
Earnings Scheduled For March 16, 2022
Companies Reporting Before The Bell • Ideanomics (NASDAQ:IDEX) is likely to report quarterly loss at $0.05 per share on revenue of $33.20 million. • Tarena... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 35 companies made new 52-week lows. 52-Week High And Low Highlights: The company with the largest market cap to set a new 52-week low was... 
Via Benzinga
Cyteir Therapeutics Announces the Appointment of Stephen Sands to Board of Directors
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics Announces First Patient Dosed in Phase 2 with CYT-0851
From Cyteir Therapeutics
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2022
Upgrades For Enova International Inc (NYSE:ENVA), Maxim Group upgraded the previous rating of Hold to Buy. For the fourth quarter, Enova International had an EPS of $1.61,... 
Via Benzinga
Cyteir Therapeutics Announces the Appointment of John F. Thero to Board of Directors
From Cyteir Therapeutics
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 41 stocks made new 52-week lows. Facts of Interest About Today's 52-Week Lows: Biogen (NASDAQ:BIIB) was the biggest company by market cap to set a... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on... 
Via Benzinga
54 Biggest Movers From Yesterday
Gainers MDJM Ltd (NASDAQ: MDJH) shares surged 35.6% to close at $2.44 on Wednesday after gaining 10% on Tuesday. GWG Holdings, Inc. (NASDAQ: GWGH) gained 31.6% to settle at $4.50... 
Via Benzinga
Cyteir Therapeutics Announces First Patient Dosed in Phase 1 Combination Trial With CYT-0851
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics Announces the Appointment of Dr. Jeffrey S. Humphrey to Board of Directors
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics to Participate in the Credit Suisse 30th Annual Healthcare Conference
From Cyteir Therapeutics
Via Business Wire
52 Biggest Movers From Yesterday
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland... 
Via Benzinga
Exposures Product Safety
Cyteir Therapeutics Selected to Join Russell 2000® Index
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics to Participate in the 19th Annual Morgan Stanley Global Healthcare Conference
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Highlights
From Cyteir Therapeutics
Via Business Wire
Cyteir Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference
From Cyteir Therapeutics
Via Business Wire
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical... 
Via Benzinga
Exposures Product Safety
61 Biggest Movers From Yesterday
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's... 
Via Benzinga
These 3 New Biotechs Have Differentiated Platforms, Technology: BofA
Following the expiry of IPO quiet periods for the recently listed Ambrx Biopharma Inc. (NASDAQ: 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback